Lack of nucleophosmin mutation in patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities

Leukemia and Lymphoma

Volumn 48, Issue 11, 2007, Pages 2141-2144

  Shiseki, Masayuki ^a   Kitagawa, Yukiko ^a   Wang, Yan Hua ^a   Yoshinaga, Kentaro ^a   Kondo, Toshiaki ^a   Kuroiwa, Hanae ^a   Okada, Michiko ^b   Mori, Naoki ^a   Motoji, Toshiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Shiseikai Dai Ni Hospital   (Japan)

Author keywords

AML; Chromosome 5; MDS; Nucleophosmin

Indexed keywords

NUCLEOPHOSMIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHROMOSOME 5Q; CLINICAL ARTICLE; DNA SEQUENCE; EXON; FEMALE; GENE AMPLIFICATION; GENE LOCUS; GENE MUTATION; GENE TARGETING; HUMAN; LEUKEMOGENESIS; MALE; MUTATIONAL ANALYSIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STRUCTURAL CHROMOSOME ABERRATION;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 5; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MUTATION; MYELODYSPLASTIC SYNDROMES; NUCLEAR PROTEINS;

EID: 36049015570     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701615900     Document Type: Article

References (24)

1. Borer, R. A., Lehner, C. E., Eppenberger, H. M. and Nigg, E. A. (1989) Major nuclear proteins shuttle between nucleus and cytoplasm. Cell, 56, pp. 379-390.
2. Cordell, J. L., Pulford, K AF, Bigerna, B., Roncador, G., Banham, A. and Colombo, E. (1999) Detection of normal and chimeric nucleophosmin in human cells. Blood, 93, pp. 632-642.
3. Dumbar, T. S., Gentry, G. and Olson, M. O. (1989) Interaction of nuclear phosphoprotein B23 with nucleic acid. Biochemistry, 79, pp. 428-437.
4. Colombo, E., Marine, J. C., Danovi, D., Falini, B. and Pelicci, P. G. (2002) Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol, 4, pp. 529-533.
5. Itahana, K., Bhat, K. P., Jin, A., Itahana, Y., Hawke, D. and Kobayashi, R. (2003) Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol Cell, 12, pp. 1151-1164.
6. Kurki, S., Peltonen, K., Latonen, L., Kiviharju, T. M., Ojala, P. M. and Meek, D. (2004) Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell, 5, pp. 465-475.
7. Falini, B., Mecucci, C., Tiacci, E., Alcalay, M., Rosati, R. and Pasqualucci, L. (2005) Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med, 352, pp. 254-266.
8. Suzuki, T., Kiyoi, H., Ozeki, K., Tomita, A., Yamaji, S. and Suzuki, R. (2005) Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia. Blood, 106, pp. 2854-2861.
9. Boissel, N., Renneville, A., Biggio, V., Philippe, N., Thomas, X. and Cayuela, J. M. (2005) Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype. Blood, 106, pp. 3618-3620.
10. Döhner, K., Schlenk, R. F., Habdank, M., Scholl, C., Rücker, F. G. and Corbacioglu, A. (2005) Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: Interaction with other gene mutations. Blood, 106, pp. 3740-3746.
11. Schnittger, S., Schoch, C., Kern, W., Mecucci, C., Tschulik, C. and Martelli, M. F. (2005) Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype. Blood, 106, pp. 3733-3739.
12. Verhaak, R GW, Goudswaard, C. S., van Putten, W., Bijl, M. A., Sanders, M. A. and Hugens, W. (2005) Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): Association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood, 106, pp. 3747-3754.
13. Thiede, C., Koch, S., Creutzig, E., Steudel, C., Illmer, T. and Schaich, M. (2006) Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood, 107, pp. 4011-4020.
14. Grisendi, S., Bernardi, R., Rossi, M., Cheng, K., Khandker, L. and Manova, K. (2005) Role of nucleophosmin in embryonic development and tumorigenesis. Nature, 473, pp. 147-153.
15. Solé, F., Espinet, B., Sanz, G. F., Cervera, J., Calasanz, M. J. and Luno, E. (2000) Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Br J Haematol, 108, pp. 346-356.
16. Xie, D., Hofmann, W. K., Mori, N., Miller, C. W., Hoelzer, D. and Koeffler, H. P. (2000) Allelotype analysis of the myelodysplastic syndrome. Leukemia, 14, pp. 805-810.
17. Horrigan, S. K., Arbieva, Z. H., Xie, H. Y., Kravarusic, J., Fulton, N. C. and Naik, H. (2000) Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31. Blood, 95, pp. 2372-2377.
18. Berger, R., Busson, M., Baranger, L., Helias, C., Lessard, M. and Dastugue, N. (2006) Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements. Leukemia, 20, pp. 319-321.
19. Nevill, T. J., Fung, H. C., Shepherd, J. D., Horsman, D. E., Nantel, S. H. and Klingemann, H. G. (1998) Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation. Blood, 92, pp. 1910-1917.
20. Caudill, J SC, Sternberg, A. J., Li, C-Y, Teferri, A., Lasho, T. L. and Steensma, D. P. (2006) C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders. Br J Haematol, 133, pp. 638-641.
21. Zhang, Y., Zhang, M., Yang, L. and Xiao, Z. (2007) NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype. Leukemia Res, 31, pp. 109-111.
22. Pasqualucci, L., Liso, A., Martelli, M. P., Bolli, N., Pacini, R. and Tabarrini, A. (2006) Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification. Blood, 108, pp. 4146-4155.
23. Falini, B., Nicoletti, I., Martelli, M. F. and Mecucci, C. (2007) Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features. Blood, 107, pp. 874-885.
24. Jaffe, E., Harris, E., Stein, N. and Vardiman, J. (2001) Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues, IARC, Lyon, France